Cannabidiol prescribing in the United States: An analysis of real-world data

Authors

Binx Yezhe Lin, University of California, San Francisco
Chloe Lessard, Virginia Tech Carilion School of Medicine
Yifan Li, Virginia Tech Carilion School of Medicine
Lisa Gong, Washington University School of Medicine in St. Louis
Ruth Ling, Washington University School of Medicine in St. Louis
Pallawi Jyotsana, Southern Illinois University School of Medicine
Jacob Steinle, Washington University School of Medicine in St. Louis
Jacob T Borodovsky, Dartmouth College
Fábio A Nascimento, Washington University School of Medicine in St. Louis
Kevin Y Xu, Washington University School of Medicine in St. Louis

Journal

Drug and Alcohol Dependence Reports

Publication Date

12-1-2024

Volume

13

First Page

100303

Document Type

Open Access Publication

DOI

10.1016/j.dadr.2024.100303

Rights and Permissions

Lin BY, Lessard C, Li Y, Gong L, Ling R, Jyotsana P, Steinle J, Borodovsky JT, Nascimento FA, Xu KY. Cannabidiol prescribing in the United States: An analysis of real-world data. Drug Alcohol Depend Rep. 2024 Nov 22;13:100303. doi: 10.1016/j.dadr.2024.100303. © 2024 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

Recommended Citation

Lin, Binx Yezhe; Lessard, Chloe; Li, Yifan; Gong, Lisa; Ling, Ruth; Jyotsana, Pallawi; Steinle, Jacob; Borodovsky, Jacob T; Nascimento, Fábio A; and Xu, Kevin Y, "Cannabidiol prescribing in the United States: An analysis of real-world data." Drug and Alcohol Dependence Reports. 13, 100303 (2024).
https://digitalcommons.wustl.edu/oa_4/6310

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.